AI assistant
Sending…
KEWAUNEE SCIENTIFIC CORP /DE/ — Director's Dealing 2013
Sep 20, 2013
34045_dirs_2013-09-20_9b93e59f-8473-4dcf-a5bb-ac95a822c4d7.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: KEWAUNEE SCIENTIFIC CORP /DE/ (KEQU)
CIK: 0000055529
Period of Report: 2013-09-18
Reporting Person: Rausch David M. (Director, President, CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2013-09-18 | Common Stock | M | 4000 | $14.9 | Acquired | 10000 | Direct |
| 2013-09-18 | Common Stock | M | 3000 | $14.69 | Acquired | 13000 | Direct |
| 2013-09-18 | Common Stock | F | 6080 | $17.05 | Disposed | 6920 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2013-09-18 | Option to Buy | $14.9 | M | 4000 | Disposed | 2017-08-22 | Common Stock (4000) | Direct |
| 2013-09-18 | Option to Buy | $14.69 | M | 3000 | Disposed | 2018-08-27 | Common Stock (3000) | Direct |
Footnotes
F1: Consideration for the exercise of the underlying option to buy was paid through a "net exercise" by directing the company to retain as payment for the total exercise cost a sufficient number of shares of Common Stock that would have been otherwise received upon this exercise as reported below on this Form 4 report.
F2: Employee stock option granted under Employee Stock Option plan under Rule 16b-3.
More from KEWAUNEE SCIENTIFIC CORP /DE/
Regulatory Filings
2026
May 1
Director's Dealing
2026
Mar 27
Interim / Quarterly Report
2026
Mar 13
Regulatory Filings
2026
Mar 11
Report Publication Announcement
2026
Feb 25
Major Shareholding Notification
2026
Feb 17
Director's Dealing
2026
Jan 8
Director's Dealing
2026
Jan 7
Director's Dealing
2026
Jan 2
Director's Dealing
2025
Dec 31